The strength of experience, the power of passion.

Indivior’s Board of Directors offers global pharmaceutical and biotechnology executive management experience, including expertise in corporate governance, science and policy, medicines development, audit, risk and financial management. The Board is collectively responsible for the long-term success of the Company and for delivering value to shareholders.

 

 
Shaun Thaxter

Shaun Thaxter

Chief Executive Officer

Read more
Mark Crossley

Mark Crossley

Chief Financial and Operations Officer

Read more
Daniel Tassé

Daniel Tassé

Senior Independent Director

Read more
Peter Bains

Peter Bains

Non-Executive Director

Read more
Tatjana May

Tatjana May

Non-Executive Director

Read more
A. Thomas McLellan, Ph.D.

A. Thomas McLellan, Ph.D.

Non-Executive Director

Read more
Lorna Parker

Lorna Parker

Non-Executive Director

Read more
Daniel J. Phelan

Daniel J. Phelan

Non-Executive Director

Read more
Lizabeth Zlatkus

Lizabeth Zlatkus

Non-Executive Director

Read more
Kathryn Hudson

Kathryn Hudson

Company Secretary

Read more